Estimated prevalence of uncontrolled hypertension and multiple cardiovascular risk factors and their associated risk of coronary heart disease in the United States

Journal of the American Society of Hypertension

Volumn 2, Issue 1, 2008, Pages 44-53

  Benner, Joshua S ^a   Smith, Timothy W ^a   Petrilla, Allison A ^a   Klingman, David ^a   Goel, Sangeeta ^a   Tang, Simon S K ^b   Wong, Nathan D ^c  

^a IQVIA   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ASCOT LLA; Cholesterol; cost; primary prevention

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; AGE; AGED; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PATIENT CARE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STROKE; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; UNSTABLE ANGINA PECTORIS;

EID: 38149009655     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2007.07.001     Document Type: Article

References (21)

1. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee [Erratum in: Circulation 2007;115:e172]. Circulation 115 (2007) e69-e171
2. Greenland P., Knoll M.D., Stamler J., Neaton J.D., Dyer A.R., Garside D.B., et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290 (2003) 891-897
3. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
4. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
5. Ford E.S., Mokdad A.H., Giles W.H., and Mensah G.A. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 107 (2003) 2185-2189
6. Law M.R., Wald N.J., and Rudnicka A.R. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326 (2003) 1423-1426
7. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362 (2003) 1527-1535
8. Julius S., Kjeldsen S.E., Weber M., Brunner H.R., Ekman S., Hansson L., et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial. Lancet 363 (2004) 2022-2031
9. Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 44 (2004) 720-732
10. LaRosa J.C., Grundy S.M., Waters D.D., Shear C., Barter P., Fruchart J.C., et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352 (2005) 1425-1435
11. Sever P.S., Dahlöf B., Poulter N.R., Wedel H., Beevers G., Caulfield M., et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial. Lancet 361 (2003) 1149-1158
12. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Data NHANES (1999-2000). National Center for Health Statistics (NCHS), Department of Health and Human Services. http://www.cdc.gov/nchs/about/major/nhanes/nhanes99_00.htm Accessed Date: January 13, 2005
13. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Data NHANES (2001-2002). National Center for Health Statistics (NCHS), Department of Health and Human Services. http://www.cdc.gov/nchs/about/major/nhanes/nhanes01-02.htm Accessed Date: January 13, 2005
14. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey Analytic Guidelines. National Center for Health Statistics (NCHS), Department of Health and Human Services. http://www.cdc.gov/nchs/data/nhanes/nhanes_general_guidelines_june_04.pdf Accessed Date: January 13, 2005
15. D'Agostino R.B., Russell M.W., Huse D.M., Ellison R.C., Silbershatz H., Wilson P.W., et al. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am Heart J 139 (2000) 272-281
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
17. Wong N.D., Pio J.R., Franklin S.S., L'Italien G.J., Kamath T.V., and Williams G.R. Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. Am J Cardiol 91 (2003) 1421-1426
18. Wong N.D., Thakral G., Franklin S.S., L'Italien G.J., Jacobs M.J., Whyte J.L., et al. Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. Am Heart J 145 (2003) 888-895
19. Russell M.W., Huse D.M., Drowns S., Hamel E.C., and Hartz S.C. Direct medical costs of coronary artery disease in the United States. Am J Cardiol 81 (1998) 1110-1115
20. US Department of Labor Bureau of Labor Statistics. Consumer Price Index - All Urban Consumers - Medical Care. www.bls.gov/cpi/home.htm Accessed Date: October 26, 2005
21. West of Scotland Coronary Prevention Study Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 97 (1998) 1440-1445